These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31466585)

  • 1. Diagnosis and Management of Cutaneous B-Cell Lymphomas.
    Malachowski SJ; Sun J; Chen PL; Seminario-Vidal L
    Dermatol Clin; 2019 Oct; 37(4):443-454. PubMed ID: 31466585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.
    Senff NJ; Noordijk EM; Kim YH; Bagot M; Berti E; Cerroni L; Dummer R; Duvic M; Hoppe RT; Pimpinelli N; Rosen ST; Vermeer MH; Whittaker S; Willemze R; ;
    Blood; 2008 Sep; 112(5):1600-9. PubMed ID: 18567836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aggressive primary cutaneous B-cell lymphomas and novel EBV+ entities].
    Lamos C; Dippel E
    Hautarzt; 2017 Sep; 68(9):727-739. PubMed ID: 28815289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of cutaneous B-cell lymphoma: recommendations of the French cutaneous lymphoma study group].
    Grange F; D'Incan M; Ortonne N; Dalac S; Laroche L; Beylot-Barry M; Delfau-Larue MH; Vergier B; Bagot M;
    Ann Dermatol Venereol; 2010; 137(8-9):523-31. PubMed ID: 20804896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management.
    Wilcox RA
    Am J Hematol; 2018 Nov; 93(11):1427-1430. PubMed ID: 30039522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous B-cell lymphomas: 2013 update on diagnosis, risk-stratification, and management.
    Wilcox RA
    Am J Hematol; 2013 Jan; 88(1):73-6. PubMed ID: 23379008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions.
    Suárez AL; Querfeld C; Horwitz S; Pulitzer M; Moskowitz A; Myskowski PL
    J Am Acad Dermatol; 2013 Sep; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of indolent cutaneous B‑cell lymphoma].
    Wobser M
    Hautarzt; 2017 Sep; 68(9):721-726. PubMed ID: 28766120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous B-cell lymphomas - pathogenesis, diagnostic workup, and therapy.
    Nicolay JP; Wobser M
    J Dtsch Dermatol Ges; 2016 Dec; 14(12):1207-1224. PubMed ID: 27992127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and Management of Cutaneous B-cell Lymphoma.
    Pinter-Brown LC
    Dermatol Clin; 2015 Oct; 33(4):835-40. PubMed ID: 26433853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas.
    Fabbri A; Cencini E; Alterini R; Rubegni P; Rigacci L; Delfino C; Puccini B; Fimiani M; Bosi A; Bocchia M; Pimpinelli N;
    Eur J Haematol; 2014 Aug; 93(2):129-36. PubMed ID: 24635751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management.
    Sokol L; Naghashpour M; Glass LF
    Cancer Control; 2012 Jul; 19(3):236-44. PubMed ID: 22710899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification.
    Suárez AL; Pulitzer M; Horwitz S; Moskowitz A; Querfeld C; Myskowski PL
    J Am Acad Dermatol; 2013 Sep; 69(3):329.e1-13; quiz 341-2. PubMed ID: 23957984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous Large B Cell Lymphoma Involving the Duodenum and the Bile Duct: a Case Report.
    Hamzaoui L; Medhioub M; Khsiba A; Mahmoudi M; Badri T; Azouz MM
    J Gastrointest Cancer; 2019 Sep; 50(3):681-683. PubMed ID: 29766412
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University.
    Haverkos B; Tyler K; Gru AA; Winardi FK; Frederickson J; Hastings J; Elkins C; Zhang X; Xu-Welliver M; Wong HK; Porcu P
    Oncologist; 2015 Oct; 20(10):1161-6. PubMed ID: 26306900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma.
    Colovic N; Jurisic V; Terzic T; Atkinson HD; Colovic M
    Arch Dermatol Res; 2009 Oct; 301(9):689-92. PubMed ID: 19495780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous primary B-cell lymphomas: from diagnosis to treatment.
    Lima M
    An Bras Dermatol; 2015; 90(5):687-706. PubMed ID: 26560215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea.
    Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS
    Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management.
    Wilcox RA
    Am J Hematol; 2015 Jan; 90(1):73-6. PubMed ID: 25535037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cutaneous B-cell lymphoma].
    Cortés B; Prins C
    Rev Med Suisse; 2014 Apr; 10(424):738, 740-3. PubMed ID: 24772806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.